We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Optimization identifies ROR1 inhibitors with improved activity and selectivity, indicating potential therapeutic benefits.
, and an optimized PK profile, marking a substantive advance toward selective ROR1 inhibitors.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: